25th Jun 2025 Plain language summary: benefits of SGLT2 inhibitor medications for people living with chronic kidney disease
17th Jan 2025 Evaluating tenapanor for managing hyperphosphatemia in dialysis patients: a plain language summary of the OPTIMIZE study